This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC) (ERIC)

This study has been terminated.
(Study terminated due to lack of resources.)
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Cardiovascular Institute of the South Clinical Research Corporation
ClinicalTrials.gov Identifier:
NCT01705509
First received: October 10, 2012
Last updated: April 5, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 31, 2017
  Primary Completion Date: March 31, 2017 (Final data collection date for primary outcome measure)